Search PDMR transactions

Notifier
Name of person with notification obligation
Nils Anders Haegerstrand
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Nils Anders Haegerstrand
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Annexin Pharmaceuticals AB (publ)
Issuer´s LEI code
5493000JP703HGPJEX27
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant 2022/2025 Acquisition 300,000 Quantity 0.21 SEK 14/06/2022 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
2022/2025 Acquisition 14/06/2022 Outside a trading venue 300,000 (Quantity) 0.21 SEK
<< Back